Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series
Abstract Background Children with rheumatic diseases (cRD) receiving immunosuppressive medications (IM) are at a higher risk for acquiring potentially lethal pathogens, including Histoplasma capsulatum (histoplasmosis), a fungal infection that can lead to prolonged hospitalization, organ damage, and...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
BMC
2021-06-01
|
| Sraith: | Pediatric Rheumatology Online Journal |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s12969-021-00581-7 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|